CapsoVision, Inc.

CV ·Healthcare, Medical Devices, United States
Analysis › Moat Score

Moat Score — CapsoVision, Inc.

Total Moat Score 12 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 4 / 5 CapsoVision holds 140+ issued patents protecting its proprietary 360-degree panoramic capsule imaging technology, plus FDA 510(k) and CE Mark clearances that are themselves a regulatory barrier to new entrants.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 1 / 5 The company has no manufacturing cost advantage and in fact depends on single-source Asian suppliers, which is a cost and supply-chain risk rather than an advantage.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 2 / 5 Differentiated panoramic imaging versus competitors' end-view systems supports premium positioning, though CapsoVision is still a small player without broad pricing leverage against Medtronic and Olympus.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 1 / 5 The CapsoCloud platform and AI-assisted detection tools modestly improve with more recorded cases, but there is no strong network effect where added users directly increase value to other users.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 3 / 5 Hospitals and GI clinics that have trained staff and built workflows around CapsoCam Plus and CapsoCloud face real retraining and procurement friction to switch to a competing capsule system.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 1 / 5 The capsule endoscopy niche supports several well-capitalized competitors (Medtronic's PillCam, Olympus, Fujifilm), and CapsoVision's small scale provides no structural barrier against these larger rivals.